Kanabo Group Plc (LON:KNB – Get Free Report) traded down 5.3% on Wednesday . The stock traded as low as GBX 0.90 ($0.01) and last traded at GBX 0.90 ($0.01). 64,657 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 427,623 shares. The stock had previously closed at GBX 0.95 ($0.01).
Kanabo Group Price Performance
The firm has a market capitalization of £6.32 million, a PE ratio of -97.50 and a beta of 3.04. The stock has a 50-day moving average price of GBX 1 and a 200 day moving average price of GBX 1.21. The company has a quick ratio of 24.36, a current ratio of 2.78 and a debt-to-equity ratio of 3.49.
Kanabo Group Company Profile
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain.
Read More
- Five stocks we like better than Kanabo Group
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Election Stocks: How Elections Affect the Stock Market
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- The 3 Best Retail Stocks to Shop for in August
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Kanabo Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kanabo Group and related companies with MarketBeat.com's FREE daily email newsletter.
